- Сharacteristics of course of community-acquired pneumonia among children from one to six years old nowadays
Сharacteristics of course of community-acquired pneumonia among children from one to six years old nowadays
SOVREMENNAYA PEDIATRIYA.2017.2(82):66-69; doi 10.15574/SP.2017.82.66
Kravchenko L. G., Kopiyka H. K., Koval L. I., Zubarenko K. O., Rizhykova T. I., Doykova K. M., Sytnyk V. V.
Odessa National Medical University, Ukraine
Odessa City Children's Clinical Hospital Ak. B.J. Reznik, Ukraine
Objective: to analyze the course of community%acquired pneumonia in children aged from one to six years at the present time.
Material and methods. The study involved 63 children aged from one to six with community%acquired radiologically confirmed pneumonia, who were admitted to the hospital. Along with the general clinical research methods, two other methods were applied — the biochemical method (serum creatinine, urea, C-reactive protein, lactate dehydrogenase) and the instrumental method (chest X%ray, ECG, pulseoximetry, according to guidline — computed tomography).
Results. The study performs the frequency analysis of the main clinical and laboratory parameters of community-acquired pneumonia among children aged one to six. It was found that the typical clinical signs of pneumonia are present in (63.49±6.06)% of children aged one to six years with community-acquired pneumonia, while pneumonic hematological criteria ascertained twice less. At the time of our research was observed a high percentage of bronchial obstruction (39.68±7.93)% in children with community-acquired pneumonia and segmental pneumonia with a predominance of preschool children 69.69% odds ratio (OR) = 3.55 (95% CI 1.25; 10.07). In the acute period of community-acquired pneumonia the study revealed an increase of lactate dehydrogenase activity in (60.31±6.16)% of cases, indicating the intensity of energy metabolism. Based on the positive dynamics of the main clinical and laboratory parameters (98,41±1,57)% of cases with communityacquired pneumonia show efficacy of the hospital therapy with empiric antibiotic therapy and pathogenetic therapy. Only one case revealed destructive complications in a child suffering from a premorbid (intrauterine hypoxia, prematurity) background and the belated initiation of therapy.
Conclusions. The study determines (98.41±1.57)% as the number of children with community-acquired pneumonia aged one to six, who, nowadays, have acute course of disease. The community acquired pneumonia revealed itself in majority of patients with typical clinical signs and X-ray segmental morphological character of inflammation. One-third of cases was accompanied by BOS syndrome.
Keywords: children one to six years, community-acquired pneumonia, course of disease
1. Kravchenko LG, Zubarenko OV, Kopiyka GK et al. 2016. Determination of etiologic spectrum of community-acquired pneumonia at age aspect. Visnik VDNZU "Ukrainska medichna stomatologichne akademia". 16; 3(55): 73-75.
2. Antypkin YG, Chumachenko NG, Lapshin VF, Umanets TR. 2016. The aspects of respiratory organs pathological conditions dynamics among child population. Sovremennaya Pediatriya. 2(74): 73-77.
3. Maidannyk VG, Yemchynska EA. 2014. Clinical guidelines for the diagnostic and treatment of community-acquired pneumonia in children from the position of evidence-based medicine. Kyiv: 43.
4. Nyankovskyy SL, Babik IV. 2015. Features of asthenic syndrome and vegetative disturbance in children with community-acquired pneumonia. Zdorovie rebenka. 3: 16-21.
5. Volosovets AP, AAbaturov AE, Besch LV et al. 2011. Results of the multicenter study "Cef-prosto" (cefpodoksym proxetil start-therapy in community-acquired pneumonia in children) in Ukraine. Sovremennaya Pediatriya. 2: 107-112.
6. Soroka ND. 2011. Beta-carotene in therapy of acute respiratory diseases in children. Detskye infekzii.1: 60-63.
7. Tatochenko VK. 2012. Respiratory organs disease in children: Practical guidance. Moscow Pedyatr. 479.
8. Haugen J, Chandyo R, Brokstad A et al. 2015. Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia. PLoS One. https://doi.org/10.1371/journal.pone.0138978
9. Erez A, Shental O, Tchebiner JZ, Laufer-Perl M, Wasserman A, Sella T, Guzner-Gur H. 2014. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. Isr Med Assoc J. 16: 439–443. PMid:25167691
10. Krenke K, Sanocki M, Urbankowska E et al. 2015. Necrotizing Pneumonia and Its Complications in Children. Adv Exp Med Biol. 857: 9-17. https://doi.org/10.1007/5584_2014_99; PMid:25468010
11. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. 2010. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 126(2): 204–213. https://doi.org/10.1542/peds.2009-3109
12. Principi N, Esposito S. 2011. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 66: 815–822. https://doi.org/10.1136/thx.2010.142604; PMid:20965930